Predictors of the need for prophylactic percutaneous endoscopic gastrostomy in head and neck cancer patients treated with concurrent chemoradiotherapy

ConclusionsProphylactic PEG is effective for patients treated with definitive CCRT and is especially required for patients with PS2 or oropharyngeal cancer.

http://link.springer.com/10.1007/s10147-021-01889-w

Source: International Journal of Clinical Oncology - June 4, 2021 Category: Cancer & Oncology Source Type: research